Palumbo Wealth Management »

C4 Therapeutics shares owned by Palumbo Wealth Management

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Palumbo Wealth Management from 13F filings

Historical chart of Palumbo Wealth Management investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Palumbo Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Palumbo Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $618k 132k 4.67

More positions owned by Palumbo Wealth Management

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Apple (AAPL)
Amazon (AMZN)
Spdr Gold Tr Gold Shs (GLD)
NVIDIA Corporation (NVDA)
Invesco Db Commdy Indx Trck Unit (DBC)
Microsoft Corporation (MSFT)
Marvell Technology (MRVL)
JPMorgan Chase & Co. (JPM)
Advanced Micro Devices (AMD)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Waste Management (WM)

View all positions for Palumbo Wealth Management

Top funds holding C4 Therapeutics

Morgan Stanley
RA Capital Management
BlackRock
Squadron Capital Management
Lynx1 Capital Management
Bain Capital Life Sciences Investors
Jpmorgan Chase & Co
Vanguard Capital Management
Citadel Advisors
Goldman Sachs Group
Daniel D. Thurber
Two Sigma Investments
Soleus Capital Management
Silverarc Capital Management
Bank of America Corporation

View all funds holding C4 Therapeutics